Puravankara seeks shareholder nod for MD's reappointment and Rs 8 Cr remuneration hike
Puravankara Limited is seeking shareholder approval for the reappointment of MD Ashish Ravi Puravankara for five years from April 1, 2026. Shareholders will also vote on enhancing his remuneration limit to ₹8 crore annually for three years, starting April 1, 2026. Remote e-voting is open from Feb 18 to March 19, 2026.
The reappointment of the Managing Director and the enhancement of their remuneration are significant decisions that could impact the company's governance and financial structure.
The announcement is a routine corporate procedure for re-appointment and remuneration adjustment, with no immediate positive or negative financial implications mentioned.
Puravankara Limited has issued a Postal Ballot Notice dated February 12, 2026, seeking approval from its members for key corporate decisions via remote e-voting. The notice addresses two special business items. The first is the proposed re-appointment of Mr. Ashish Ravi Puravankara as Managing Director for a five-year term, commencing April 01, 2026, and concluding on March 31, 2031. This reappointment is subject to an Ordinary Resolution.
The second item seeks approval for enhancing the overall remuneration limit for Mr. Ashish Ravi Puravankara, as Managing Director, for a period of three years from April 01, 2026, to March 31, 2029. This proposal requires a Special Resolution and includes an enhanced annual remuneration limit of ₹8,00,00,000 (Rupees Eight Crores). The remuneration will comprise salary, perquisites, allowances, and performance incentives, with specific details on perquisites like housing, medical, and leave travel expenses outlined. The Board of Directors is authorized to revise these terms within the approved limit.
The remote e-voting period will commence on Wednesday, February 18, 2026, at 9:00 a.m. (IST) and will conclude on Thursday, March 19, 2026, at 5:00 p.m. (IST). The company is facilitating this electronic voting process through NSDL. A cut-off date of Friday, February 06, 2026, was set for determining eligible members to receive the notice.
What to do with a filing like this
Puravankara Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Puravankara Limited. Read the original for the full detail.